Table 1.

Relationship between NAT10 expression level and clinical characteristics of HCC patients.

Clinical features	Number	NAT10			Positive rate (%)	Z/χ2	P
		Negative	Low	High
Sex						0.265	0.791
Male	80	6	28	46	92.5
Female	20	2	7	11	90.0
Age						0.542	0.588
≤60 years	48	2	18	28	95.8
>60 years	52	6	17	29	88.5
History of hepatitis						7.217	0.027*
Positive	76	3	27	46	96.0
Negative	24	5	8	11	79.0
History of cirrhosis						8.371	0.015*
Positive	78	3	29	46	96.2
Negative	22	5	6	11	77.3
Tumor size						1.139	0.255
≤5 cm	59	5	23	31	91.5
>5 cm	40	3	11	26	92.5
Differentiation						2.166	0.339
Low	30	2	13	15	93.3
Middle	64	6	21	37	90.6
High	6	0	1	5	100.0
Single/Multiple tumor						1.416	0.157
Single	83	8	30	45	90.4
Multiple	17	0	5	12	100.0
AFP						0.987	0.324
Normal	43	6	14	23	86.0
Abnormal	57	2	21	34	96.5
ALT						1.296	0.195
Normal	35	2	10	23	94.3
Abnormal	65	6	25	34	90.8
AST						0.304	0.761
Normal	40	4	12	24	90.0
Abnormal	60	4	23	33	93.3

NAT10 N-acetyltransferase 10, AFP alpha-fetoprotein, ALT alanine aminotransferase, AST aspartate aminotransferase.

*p value <0.05.